Announcements Trials

Browse Landscape

Phase

Status

Completed 3 Recruiting 2 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 40 Breast Neoplasms 38 Prostatic Neoplasms 24 Colorectal Neoplasms 23 Uterine Cervical Neoplasms 16 Carcinoma, Non-Small-Cell Lung 13 Anxiety Disorders 13 Stomach Neoplasms 9 Lymphoma, Follicular 9 Leukemia, Myeloid, Acute 9 Carcinoma, Hepatocellular 9 Brain Neoplasms 9 Lung Neoplasms 8 Head and Neck Neoplasms 8 Urinary Bladder Neoplasms 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Esophageal Neoplasms 7 Sarcoma 6 Ovarian Neoplasms 6 Esophageal Squamous Cell Carcinoma 6 Depression 6 Colonic Neoplasms 6 Uterine Cervical Dysplasia 5 Small Cell Lung Carcinoma 5 Pain 5 Glioma 5 Epilepsy 5 Dementia 5 Cholangiocarcinoma 5 Squamous Cell Carcinoma of Head and Neck 4

Interventions

bismuth tripotassium dicitrate 1 Tetracycline 1 Tablets 1 Metronidazole 1 Lacteol 1 Esomeprazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × Interventional × Dysbiosis × Clear all

NCT04527055 2024-06-24

Bsm10

National Cheng-Kung University Hospital

Phase 4 Enrolling by invitation

Dysbiosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡